Projects per year
Group: The Wülfing laboratory
The research focus of the Wuelfing laboratory is to understand how T cell signalling is amplified or attenuated in health and disease. To gain unique access to the system-wide, complex processes driving such signal tuning, we directly determine signalling as it occurs in time and space inside primary T cells activated by antigen presenting cells with large-scale live cell imaging approaches.
T cells are central regulatory and effector cells of the immune system. A single receptor, the T cell receptor, mediates immunological recognition. However, multiple receptor families then amplify or attenuate the T cell receptor signal to mediate physiological adaptation in health and disease. We investigate the complex signalling processes mediating such adaptation. Understanding how cellular function is regulated in complex signalling networks with dozens of interacting proteins is a critical, general challenge in current biomedical science. A critical component of signalling complexity is that proteins are rarely evenly distributed throughout cells but enrich at particular locations at particular times. At the system scale such spatiotemporal organisation determines how regulatory information flows through signalling networks in time and space. By combining large scale and quantitative live cell imaging of primary T cells activated by antigen presenting cells with the manipulation of spatiotemporal features of signalling intermediates we harness the regulatory information encoded in signalling organisation to understand and control the regulation of T cell function. Thus we address the mutual relation between T cell actin regulation and signalling in costimulation and the tyrosine kinase Itk. We investigate how cytotoxic lymphocytes kill tumour target cells and why such killing is often suppressed inside the tumour microenvironment. We study changes in T cell signalling in the induction of immunological tolerance upon therapy of autoimmune disease.
The research is described in more detail on our laboratory website http://www.bristol.ac.uk/cellmolmed/research/infect-immune/wuelfing/
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Dive into details
Select a country/territory to view shared publications and projects
- 3 Finished
1/10/18 → 30/09/19
Wuelfing, C. & Dovedi, S., 1 Feb 2023, In: Nature. 614, 7948, p. 416-418 3 p.
Research output: Contribution to journal › Review article (Academic Journal)
Adenosine 2A receptor and TIM3 suppress cytolytic killing of tumor cells via cytoskeletal polarizationEdmunds, G. L., Wong, C. C. W., Ambler, R., Milodowski, E. J., Alamir, H., Cross, S. J., Galea, G., Wülfing, C. & Morgan, D. J., 22 Jan 2022, (E-pub ahead of print) In: Communications Biology. 5, 1, 17 p., 9.
Research output: Contribution to journal › Article (Academic Journal) › peer-reviewOpen AccessFile2 Citations (Scopus)87 Downloads (Pure)
A LAT-Based Signaling Complex in the Immunological Synapse as Determined with Live Cell Imaging Is Less Stable in T Cells with Regulatory Capabilityet al., 17 Feb 2021, In: Cells. 10, 2, p. 1-23 23 p., 418.
Research output: Contribution to journal › Article (Academic Journal) › peer-reviewOpen AccessFile2 Citations (Scopus)80 Downloads (Pure)
Wuelfing, C. (Creator), University of Bristol, 27 Jul 2023
- 1 Membership of external research organisation
MMBioS Biomedical Technology Research Center in High Performance Computing for Multiscale Modeling of Biological Systems (External organisation)
Christoph Wuelfing (Contributor)Aug 2012 → Jul 2017
Activity: Membership types › Membership of external research organisation